CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate Kylo-11 in patients with atherosclerotic cardiovascular disease and elevated lipoprotein(a) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Kylonova (Xiamen) Biopharma co., LTD. | Conditions: Lipoprotein Disorder | Phase 2 | Status: RECRUITING